Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002.

PubWeight™: 6.78‹?› | Rank: Top 1%

🔗 View Article (PMID 16362880)

Published in J Infect Dis on December 15, 2005

Authors

Matthew J Kuehnert1, Deanna Kruszon-Moran, Holly A Hill, Geraldine McQuillan, Sigrid K McAllister, Gregory Fosheim, Linda K McDougal, Jasmine Chaitram, Bette Jensen, Scott K Fridkin, George Killgore, Fred C Tenover

Author Affiliations

1: National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. mkuehnert@cdc.gov

Associated clinical trials:

Oral Doxycycline for the Prevention of Syphilis in Men Who Have Sex With Men | NCT02864550

Articles citing this

(truncated to the top 100)

Structure, function and diversity of the healthy human microbiome. Nature (2012) 30.40

Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol (2009) 10.42

Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev (2010) 9.82

The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev (2010) 4.22

Frequent emergence and limited geographic dispersal of methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A (2008) 3.52

Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog (2010) 3.11

Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature (2010) 2.85

The human nasal microbiota and Staphylococcus aureus carriage. PLoS One (2010) 2.50

Characterization of Staphylococcus aureus isolates from nasal cultures collected from individuals in the United States in 2001 to 2004. J Clin Microbiol (2008) 2.16

Antibiotic resistant Staphylococcus aureus: a paradigm of adaptive power. Curr Opin Microbiol (2007) 1.93

Surveillance cultures for detection of methicillin-resistant Staphylococcus aureus: diagnostic yield of anatomic sites and comparison of provider- and patient-collected samples. Infect Control Hosp Epidemiol (2009) 1.85

Analysis of typing methods for epidemiological surveillance of both methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains. J Clin Microbiol (2007) 1.80

agr-Dependent interactions of Staphylococcus aureus USA300 with human polymorphonuclear neutrophils. J Innate Immun (2010) 1.77

Molecular epidemiology of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from global clinical trials. J Clin Microbiol (2008) 1.73

Epidemiology of Staphylococcus aureus colonization in nursing home residents. Clin Infect Dis (2008) 1.72

Diversity of staphylococcal cassette chromosome mec structures in methicillin-resistant Staphylococcus epidermidis and Staphylococcus haemolyticus strains among outpatients from four countries. Antimicrob Agents Chemother (2008) 1.59

Genetic diversity and ecological success of Staphylococcus aureus strains colonizing humans. Appl Environ Microbiol (2008) 1.58

Molecular mechanisms of Staphylococcus aureus iron acquisition. Annu Rev Microbiol (2011) 1.51

Species-level analysis of DNA sequence data from the NIH Human Microbiome Project. PLoS One (2012) 1.49

Prevalence of methicillin-resistant Staphylococcus aureus nasal colonization among Taiwanese children in 2005 and 2006. J Clin Microbiol (2007) 1.48

Staphylococcal and streptococcal superantigen exotoxins. Clin Microbiol Rev (2013) 1.48

Skin microbiome: genomics-based insights into the diversity and role of skin microbes. Trends Mol Med (2011) 1.45

The bicomponent pore-forming leucocidins of Staphylococcus aureus. Microbiol Mol Biol Rev (2014) 1.32

Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial. Antimicrob Agents Chemother (2007) 1.30

Strain-relatedness of methicillin-resistant Staphylococcus aureus isolates recovered from patients with repeated infection. Clin Infect Dis (2008) 1.24

Overlapping population structures of nasal isolates of Staphylococcus aureus from healthy Dutch and American individuals. J Clin Microbiol (2007) 1.23

Lipids including cholesteryl linoleate and cholesteryl arachidonate contribute to the inherent antibacterial activity of human nasal fluid. J Immunol (2008) 1.22

Factors associated with nasal colonization of methicillin-resistant Staphylococcus aureus among healthy children in Taiwan. J Clin Microbiol (2010) 1.21

Extreme genetic diversity of methicillin-resistant Staphylococcus epidermidis strains disseminated among healthy Japanese children. J Clin Microbiol (2008) 1.21

Perspectives on the etiology of chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg (2010) 1.20

Alpha and beta chains of hemoglobin inhibit production of Staphylococcus aureus exotoxins. Biochemistry (2007) 1.19

Subcellular localization of the Staphylococcus aureus heme iron transport components IsdA and IsdB. Infect Immun (2009) 1.18

Two heme-dependent terminal oxidases power Staphylococcus aureus organ-specific colonization of the vertebrate host. MBio (2013) 1.17

Antimicrobial susceptibility patterns and staphylococcal cassette chromosome mec types of, as well as Panton-Valentine leukocidin occurrence among, methicillin-resistant Staphylococcus aureus isolates from children and adults in middle Tennessee. J Clin Microbiol (2006) 1.17

Hemoglobin promotes Staphylococcus aureus nasal colonization. PLoS Pathog (2011) 1.17

Methicillin-susceptible, non-multiresistant methicillin-resistant and multiresistant methicillin-resistant Staphylococcus aureus infections: a clinical, epidemiological and microbiological comparative study. Eur J Clin Microbiol Infect Dis (2008) 1.16

Staphylococcus aureus in the community: colonization versus infection. PLoS One (2009) 1.16

A systematic literature review and meta-analysis of factors associated with methicillin-resistant Staphylococcus aureus colonization at time of hospital or intensive care unit admission. Infect Control Hosp Epidemiol (2013) 1.16

Evaluation of the impact of direct plating, broth enrichment, and specimen source on recovery and diversity of methicillin-resistant Staphylococcus aureus isolates among HIV-infected outpatients. J Clin Microbiol (2011) 1.15

Coagulase positive staphylococcal colonization of humans and their household pets. Can Vet J (2009) 1.14

A battle for iron: host sequestration and Staphylococcus aureus acquisition. Microbes Infect (2011) 1.12

Epidemiology and risk factors for Staphylococcus aureus colonization in children in the post-PCV7 era. BMC Infect Dis (2009) 1.11

The heme sensor system of Staphylococcus aureus. Contrib Microbiol (2009) 1.08

Innate Stat3-mediated induction of the antimicrobial protein Reg3γ is required for host defense against MRSA pneumonia. J Exp Med (2013) 1.08

Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids. Biomaterials (2010) 1.08

Nasal Carriage and Resistance Pattern of Multidrug Resistant Staphylococcus aureus Among Healthy Children in Kashan, Iran. Iran Red Crescent Med J (2014) 1.07

Presence of genes encoding panton-valentine leukocidin is not the primary determinant of outcome in patients with hospital-acquired pneumonia due to Staphylococcus aureus. J Clin Microbiol (2012) 1.04

Colonization and infection of the skin by S. aureus: immune system evasion and the response to cationic antimicrobial peptides. Int J Mol Sci (2014) 1.03

Nasal carriage of multi-drug resistant Staphylococcus aureus in healthy inhabitants of Amassoma in Niger delta region of Nigeria. Afr Health Sci (2011) 1.01

Unusually high prevalence of nosocomial Panton-Valentine leukocidin-positive Staphylococcus aureus isolates in Cape Verde Islands. J Clin Microbiol (2006) 1.00

Unusually high prevalence of panton-valentine leukocidin genes among methicillin-sensitive Staphylococcus aureus strains carried in the Indonesian population. J Clin Microbiol (2008) 0.99

Longitudinal nasopharyngeal carriage and antibiotic resistance of respiratory bacteria in indigenous Australian and Alaska native children with bronchiectasis. PLoS One (2013) 0.99

Alpha-toxin promotes Staphylococcus aureus mucosal biofilm formation. Front Cell Infect Microbiol (2012) 0.97

Evolutionary blueprint for host- and niche-adaptation in Staphylococcus aureus clonal complex CC30. Front Cell Infect Microbiol (2012) 0.95

The increasing problem of wound bacterial burden and infection in acute and chronic soft-tissue wounds caused by methicillin-resistant Staphylococcus aureus. J Burns Wounds (2007) 0.95

Influence of host genetics and environment on nasal carriage of staphylococcus aureus in danish middle-aged and elderly twins. J Infect Dis (2012) 0.95

Bacterial Hypoxic Responses Revealed as Critical Determinants of the Host-Pathogen Outcome by TnSeq Analysis of Staphylococcus aureus Invasive Infection. PLoS Pathog (2015) 0.95

Exoproteome of Staphylococcus aureus reveals putative determinants of nasal carriage. J Proteome Res (2011) 0.95

Methicillin-resistant Staphylococcus aureus colonization of the groin and risk for clinical infection among HIV-infected adults. Emerg Infect Dis (2013) 0.94

Staphylococcus aureus nasal colonization in preoperative orthopaedic outpatients. Clin Orthop Relat Res (2008) 0.94

Prevalence and risk factor analysis for methicillin-resistant Staphylococcus aureus nasal colonization in children attending child care centers. J Clin Microbiol (2010) 0.94

Persistence survey of toxic shock syndrome toxin-1 producing Staphylococcus aureus and serum antibodies to this superantigen in five groups of menstruating women. BMC Infect Dis (2010) 0.93

Rapid detection of Panton-Valentine leukocidin in Staphylococcus aureus cultures by use of a lateral flow assay based on monoclonal antibodies. J Clin Microbiol (2012) 0.93

Predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swab PCR assay for MRSA pneumonia. Antimicrob Agents Chemother (2013) 0.92

The AgrD N-terminal leader peptide of Staphylococcus aureus has cytolytic and amyloidogenic properties. Infect Immun (2014) 0.91

Superantigens of Staphylococcus aureus from patients with diabetic foot ulcers. J Infect Dis (2014) 0.91

Nasal colonization of and clonal transmission of methicillin-susceptible Staphylococcus aureus among Chinese military volunteers. J Clin Microbiol (2009) 0.91

Fructose-enhanced reduction of bacterial growth on nanorough surfaces. Int J Nanomedicine (2012) 0.90

Prevalence of Staphylococcus aureus and lack of its lytic bacteriophages in the anterior nares of patients and healthcare workers at a rural clinic. Clin Med Res (2010) 0.90

Structure and function of the human skin microbiome. Trends Microbiol (2013) 0.89

Genome wide association study of SNP-, gene-, and pathway-based approaches to identify genes influencing susceptibility to Staphylococcus aureus infections. Front Genet (2014) 0.89

Molecular analysis of Staphylococcus epidermidis strains isolated from community and hospital environments in China. PLoS One (2013) 0.89

Longitudinal genetic analyses of Staphylococcus aureus nasal carriage dynamics in a diverse population. BMC Infect Dis (2013) 0.89

Community-associated methicillin-resistant Staphylococcus aureus: the way to the wound is through the nose. J Infect Dis (2005) 0.89

Methicillin-sensitive and methicillin-resistant Staphylococcus aureus nasal carriage in a random sample of non-hospitalized adult population in northern Germany. PLoS One (2014) 0.87

scFv-based "Grababody" as a general strategy to improve recruitment of immune effector cells to antibody-targeted tumors. Cancer Res (2013) 0.87

Clearance of experimental cutaneous Staphylococcus aureus infections in mice. Arch Dermatol Res (2010) 0.86

Vancomycin and nephrotoxicity: just another myth? J Trauma Acute Care Surg (2013) 0.86

Increased prevalence of methicillin-resistant Staphylococcus aureus nasal colonization in household contacts of children with community acquired disease. BMC Infect Dis (2012) 0.86

Modeling methicillin-resistant Staphylococcus aureus in hospitals: transmission dynamics, antibiotic usage and its history. Theor Biol Med Model (2012) 0.86

Colonization with Staphylococcus aureus and methicillin-resistant S. aureus among a sample of homeless individuals, Ohio. Infect Control Hosp Epidemiol (2009) 0.85

Risk factors for Staphylococcus aureus nasal colonization in Danish middle-aged and elderly twins. Eur J Clin Microbiol Infect Dis (2013) 0.85

Meta-analysis of methicillin-resistant Staphylococcus aureus colonization and risk of infection in dialysis patients. J Am Soc Nephrol (2014) 0.85

Propionibacterium-produced coproporphyrin III induces Staphylococcus aureus aggregation and biofilm formation. MBio (2014) 0.84

Analysis of Virulence Genes Among Methicillin Resistant Staphylococcus aureus (MRSA) Strains. Jundishapur J Microbiol (2014) 0.84

Antibiotic Resistance of Commensal Staphylococcus aureus and Coagulase-Negative Staphylococci in an International Cohort of Surgeons: A Prospective Point-Prevalence Study. PLoS One (2016) 0.84

Induction of the staphylococcal proteolytic cascade by antimicrobial fatty acids in community acquired methicillin resistant Staphylococcus aureus. PLoS One (2012) 0.84

Nasal carriage of Staphylococcus aureus in Botucatu, Brazil: a population-based survey. PLoS One (2014) 0.83

Prevalence of community-associated meticillin-resistant Staphylococcus aureus and Panton-Valentine leucocidin-positive S. aureus in general practice patients with skin and soft tissue infections in the northern and southern regions of The Netherlands. Eur J Clin Microbiol Infect Dis (2011) 0.83

Staphlyococcus aureus phenol-soluble modulins stimulate the release of proinflammatory cytokines from keratinocytes and are required for induction of skin inflammation. Infect Immun (2015) 0.83

Structure and function of the genomically encoded fosfomycin resistance enzyme, FosB, from Staphylococcus aureus. Biochemistry (2014) 0.83

Hydrogel Retaining Toxin-Absorbing Nanosponges for Local Treatment of Methicillin-Resistant Staphylococcus aureus Infection. Adv Mater (2015) 0.83

Risk Factors for Methicillin Resistant Staphylococcus aureus Nasal Colonization of Healthy Children. Jundishapur J Microbiol (2014) 0.82

Staphylococcus aureus: Screening for Nasal Carriers in a Community Setting with Special Reference to MRSA. Scientifica (Cairo) (2014) 0.82

Methicillin-resistant Staphylococcus aureus colonization in schoolteachers in Ontario. Can J Infect Dis Med Microbiol (2008) 0.82

Methicillin-Resistant Staphylococcus aureus Carriage among Students at a Historically Black University: A Case Study. Int J Microbiol (2013) 0.82

Increasing prevalence of nasal and rectal colonization with methicillin-resistant Staphylococcus aureus in children with cancer. Pediatr Blood Cancer (2010) 0.82

Use of Oral Doxycycline for Community-acquired Methicillin-resistant Staphylococcus aureus (CA-MRSA) Infections. J Clin Aesthet Dermatol (2009) 0.81

Differential activation of Staphylococcus aureus heme detoxification machinery by heme analogues. J Bacteriol (2014) 0.81

Cationic methacrylate polymers as topical antimicrobial agents against Staphylococcus aureus nasal colonization. Biomacromolecules (2014) 0.81

Articles by these authors

Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA (2007) 26.98

Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med (2006) 18.83

Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol (2003) 16.45

NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol (2008) 13.49

Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet (2005) 12.54

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis (2011) 11.49

Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol (2002) 10.88

Prevalence of HPV infection among females in the United States. JAMA (2007) 10.55

Multistate point-prevalence survey of health care-associated infections. N Engl J Med (2014) 8.78

Burden of Clostridium difficile infection in the United States. N Engl J Med (2015) 8.17

Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science (2003) 7.73

Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med (2003) 7.52

Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis (2002) 7.03

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis (2011) 6.71

A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med (2005) 6.14

Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. J Infect Dis (2013) 6.04

Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J Clin Microbiol (2006) 5.97

Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing beta-lactamase KPC-2. Antimicrob Agents Chemother (2003) 5.80

Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use. Clin Infect Dis (2004) 5.67

Combating antimicrobial resistance: policy recommendations to save lives. Clin Infect Dis (2011) 5.58

Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis (2008) 5.41

Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis (2002) 5.23

Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med (2008) 5.13

Health care-associated invasive MRSA infections, 2005-2008. JAMA (2010) 4.79

Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis (2005) 4.52

Epidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification. Proc Natl Acad Sci U S A (2008) 4.38

Better tests, better care: improved diagnostics for infectious diseases. Clin Infect Dis (2013) 4.27

Effect of nonpayment for preventable infections in U.S. hospitals. N Engl J Med (2012) 4.19

The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis (2007) 3.93

Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J Clin Microbiol (2003) 3.89

Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA. J Antimicrob Chemother (2009) 3.82

Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrob Agents Chemother (2004) 3.44

The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004. Clin Infect Dis (2007) 3.42

Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003. J Clin Microbiol (2005) 3.41

Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Clin Infect Dis (2003) 3.39

Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage. Clin Infect Dis (2005) 3.25

Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002. Ann Intern Med (2007) 3.20

Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. JAMA (2006) 3.11

Toxoplasma gondii infection in the United States, 1999 2004, decline from the prior decade. Am J Trop Med Hyg (2007) 3.09

Methicillin-resistant-Staphylococcus aureus hospitalizations, United States. Emerg Infect Dis (2005) 3.09

Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007. JAMA (2009) 3.06

Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone. Lancet (2005) 2.99

An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus. Clin Infect Dis (2006) 2.98

Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis (2006) 2.79

The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis (2010) 2.52

Swab materials and Bacillus anthracis spore recovery from nonporous surfaces. Emerg Infect Dis (2004) 2.46

Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004. J Infect Dis (2009) 2.43

Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure. Clin Infect Dis (2004) 2.30

Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system. J Antimicrob Chemother (2009) 2.28

Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season. Ann Emerg Med (2008) 2.27

Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors. Emerg Infect Dis (2006) 2.25

Characterization of Staphylococcus aureus isolates from nasal cultures collected from individuals in the United States in 2001 to 2004. J Clin Microbiol (2008) 2.16

Results of disk diffusion testing with cefoxitin correlate with presence of mecA in Staphylococcus spp. J Clin Microbiol (2005) 2.12

Surface sampling methods for Bacillus anthracis spore contamination. Emerg Infect Dis (2002) 2.11

National seroprevalence and risk factors for Zoonotic Toxocara spp. infection. Am J Trop Med Hyg (2008) 2.07

Characterization of methicillin-resistant Staphylococcus aureus isolates collected in 2005 and 2006 from patients with invasive disease: a population-based analysis. J Clin Microbiol (2009) 2.06

Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan. Antimicrob Agents Chemother (2007) 2.01

Emergence of community-associated methicillin resistant Staphylococcus aureus in Hawaii, 2001-2003. J Infect (2006) 1.98

Epidemiologic distribution of the arginine catabolic mobile element among selected methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates. J Clin Microbiol (2007) 1.92

Racial and ethnic differences in the seroprevalence of 6 infectious diseases in the United States: data from NHANES III, 1988-1994. Am J Public Health (2004) 1.91

Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States. Antimicrob Agents Chemother (2008) 1.89

Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 beta-lactamase: defining a unique family of class C enzymes. Antimicrob Agents Chemother (2005) 1.88

Seroprevalence of measles antibody in the US population, 1999-2004. J Infect Dis (2007) 1.87

Antimicrobial susceptibility testing of Bacillus anthracis: comparison of results obtained by using the National Committee for Clinical Laboratory Standards broth microdilution reference and Etest agar gradient diffusion methods. J Clin Microbiol (2002) 1.83

High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm. Antimicrob Agents Chemother (2006) 1.77

Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children's Hospital. Pediatr Infect Dis J (2004) 1.75